Pancreatic Cancer Research

ResearcherSichuan UniversityActive in the last 2 years

Ruomeng Liu

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5013041184. Sources: OpenAlex.

Their work

Papers
2
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2025: 1 paper · 2026: 1 paper

Papers 2

  1. Investigation of a 47Sc-radiolabelled PDGFRβ-targeted affibody in SPECT imaging and radiotherapy for pancreatic cancer. Co-author DOI 10.1186/s12885-025-15506-w↗
  2. 64Cu Radiolabeled PDGFRβ-Targeting Affibody for PET Imaging in Pancreatic Cancer. Co-author DOI 10.1021/acs.molpharmaceut.4c01368↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Li Zhao · 2 shared papers, 2025–2026 · strength 0.54
  2. Huawei Cai · 1 shared paper, 2026 · strength 0.30
  3. Nengwen Ke · 1 shared paper, 2025 · strength 0.24
  4. Ruiman Geng · 1 shared paper, 2025 · strength 0.24
  5. Huawei Cai · 1 shared paper, 2025 · strength 0.24

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.